AMIDOMETHYL SUBSTITUTED 1-(CARBOXYALKYL)-CYCLOPENTYLCARBONYLAMINO-BENZAZEPINE-N-ACETIC ACID DERIVATIVES, PROCESS AND INTERMEDIATE PRODUCTS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THESE COMPO

AMIDOMETHYL SUBSTITUTED 1-(CARBOXYALKYL)-CYCLOPENTYLCARBONYLAMINO-BENZAZEPINE-N-ACETIC ACID DERIVATIVES, PROCESS AND INTERMEDIATE PRODUCTS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THESE COMPO

Described are novel compounds with neutral endopeptidase (NEP) and/or human soluble endopeptidase (hSEP) inhibitory activity of the general formula (I), wherein the substituents R1, R2 , R3 and R4 have the meanings given in the description and also medicaments containing these compounds, in particul...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PAHL, AXEL, MESSINGER, JOSEF, HOEFER, CONSTANZE, WESKE, MICHAEL, ZIEGLER, DIETER, IKONOMIDOU, HRISSANTHI, KARIMI-NEJAD, YASMIN, FISCHER, YVAN, TURSKI, LECHOSLAW, MICHAELIS, KATHRIN, HOELTJE, DAGMAR
Format: Patent
Sprache:eng ; fre
Schlagworte:
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Described are novel compounds with neutral endopeptidase (NEP) and/or human soluble endopeptidase (hSEP) inhibitory activity of the general formula (I), wherein the substituents R1, R2 , R3 and R4 have the meanings given in the description and also medicaments containing these compounds, in particular medicaments suitable for treating or preventing cardiovascular diseases, sexual dysfunction and/or adverse conditions associated with apoptosis. La présente invention concerne de nouveaux composés présentant une activité d'inhibition d'endopeptidase neutre (NEP) et/ou d'endopeptidase soluble humaine (hSEP), de formule générale (I), où les substituants R?1¿, R?2¿, R?3¿ et R?4¿ ont les significations données dans la description, ainsi que des médicaments contenant ces composés, notamment des médicaments conçus pour traiter ou prévenir des maladies cardiovasculaires, des dysfonctionnements sexuels et/ou des états pathologiques associés à une apoptose.